BPC-157 vs TB-500

BPC-157 vs TB-500 — how these two tissue-repair research peptides compare by mechanism, molecular data and research focus. Research Use Only.

BPC-157 vs TB-500 at a glance

BPC-157 TB-500
Class / mechanism Synthetic 15-amino-acid peptide (partial sequence of a gastric-juice protein) Synthetic actin-binding fragment of Thymosin Beta-4
Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)
CAS number 137525-51-0 77591-33-4
Research focus Tissue repair, angiogenesis, cytoprotection, GI-mucosa research Actin binding, cytoskeletal signaling, cell migration
Form Lyophilized powder Lyophilized powder
Storage Lyophilized: -20°C long-term; protect from light and moisture -20°C, protected from light

What’s the difference?

Both BPC-157 and TB-500 are widely used in tissue-repair research, but they act through different mechanisms. BPC-157 is investigated in angiogenesis, cytoprotection and gastrointestinal-mucosa models, while TB-500 — a fragment of the actin-binding protein Thymosin Beta-4 — is studied for actin binding, cytoskeletal signaling and cell migration. Because the mechanisms are complementary, the two are sometimes examined together, for example in the GLOW research blend.

Which to use in research

In research design, BPC-157 is typically selected where gut, angiogenesis or cytoprotection endpoints are of interest, and TB-500 where actin, cytoskeletal or cell-migration endpoints are the focus. Both are supplied as lyophilised powder and reconstituted the same way.

Handling

All are supplied as lyophilised powder for reconstitution in bacteriostatic or sterile water. See the reconstitution guide and calculator. Each lot ships with a lot-specific Certificate of Analysis.

Learn more

Read the individual overviews: BPC-157 research overview · TB-500 research overview.

Buy for research

Frequently asked questions

Are BPC-157 and TB-500 the same?

No. BPC-157 is a synthetic 15-amino-acid peptide based on a gastric-juice protein sequence, while TB-500 is a synthetic actin-binding fragment of Thymosin Beta-4. They are studied through different mechanisms.

Can BPC-157 and TB-500 be studied together?

Yes. Because their research pathways are complementary they are sometimes examined together, as in the GLOW blend that combines them with GHK-Cu.

Part of our research peptides handbook.

Research Use Only. This information is provided for educational purposes for qualified researchers. All products are sold strictly for in-vitro laboratory research and development — not for human or animal use, and not intended to diagnose, treat, cure, or prevent any disease.